UNSPSC 51284126: Cefditoren pivoxil

This classification denotes a cephalosporin antibiotic with the molecular formula C25H28N6O7S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 78THA212DH, chemically known as cefditoren pivoxil, me-1207, meiact but more generally known as cefditoren pivoxil, which bears US NIH Compound Identifier 444006. European Medicines Agency schedules Cefditoren pivoxil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01112MIG.

Most nations, for tariff and trade purposes, schedule cefditoren pivoxil under HS 29419000 and SITC 54139. As of Q4 2014, CEFDITOREN PIVOXIL remains US FDA's Preferred Term for this commodity. Cefditoren pivoxil bears US NLM identifiers UMLS ID C0245519 and NCI Concept Code C47434. SMILES: CC1C(SCN1)/C=C\C2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4CSC(N4)N)SC2)C(=O)OCOC(=O)C(C)(C)C.

UNSPSC 51284126 Cefditoren pivoxil is a Commodity code that does not map to the recent state and local contract opportunities recorded under it. The code nominally describes a specific oral cephalosporin antibiotic, yet the four most recent solicitations posted under this code—covering naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals with over-the-counter products—target broad pharmaceutical procurement, medical supply distribution, and pharmacy benefit management capabilities rather than a single named drug product. The mismatch suggests either a data-entry error in the opportunity-tagging workflow or a systematic misalignment between the code's narrow pharmaceutical-name scope and the way state and local procurement offices are classifying their drug and medical-supply purchases.

The issuing bodies include a county health department (Seminole County, Florida), a state health and human services agency (Texas HHS Commission), a city fire department (City of Tampa), and a multistate cooperative purchasing alliance (Minnesota MMCAP, with Oregon participation). The geographic spread spans Florida, Texas, Minnesota, and Oregon. Because the code's nominal scope does not align with the actual work being solicited, firms pursuing pharmaceutical manufacturing or drug-supply contracts should verify the correct UNSPSC classification before responding to opportunities tagged under 51284126. The opportunities themselves—ranging from emergency-response medical supplies (Tampa IFB 26P00145, due March 13, 2026) to cooperative-purchasing generic-drug agreements (MMCAP RFP S1070000015802, due March 26, 2026)—represent genuine state and local pharmaceutical and medical-supply demand, but relying on this code to identify them carries a high risk of missed opportunities or wasted effort on misclassified solicitations.